M&A volume may shift from hospice to home health

M&A volume may shift from hospice to home health 
Hospice News, by Jim Parker, 3/26/24 
Though many expect a hospice M&A rebound in 2024, the scales are tipping in favor of home health companies among buyers. Generally, signs point to heightened buyer activity this year, particularly among private equity as interest rates start to come down.